Center for Scientific Review; Notice of Closed Meetings, 3670-3671 [2024-01026]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES1
3670
Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices
redesignate areas within the United
States for inclusion in or exclusion from
a PRCDA. 42 CFR 136.22(b). The
regulations require that certain criteria
must be considered before any
redesignation is made. The criteria are
as follows:
(1) The number of Indians residing in
the area proposed to be so included or
excluded;
(2) Whether the Tribal governing body
has determined that Indians residing in
the area near the reservation are socially
and economically affiliated with the
Tribe;
(3) The geographic proximity to the
reservation of the area whose inclusion
or exclusion is being considered; and
(4) The level of funding which would
be available for the provision of PRC.
Additionally, the regulations require
that any redesignation of a PRCDA must
be made in accordance with the
procedures of the Administrative
Procedure Act (5 U.S.C. 553). 42 CFR
136.22(c). In compliance with this
requirement, the IHS is publishing this
Notice and requesting public comments.
The Mashantucket Pequot Tribal
Nation’s (MPTN, or Tribe) reservation is
located in New London County,
Connecticut. The PRC Program is
operated as a Tribal Health Program by
the MPTN in Mashantucket, CT. The
MPTN estimates that approximately 32
Tribal members and MPTN employees
who are members of other federally
recognized Tribes reside in the
proposed expansion counties, and
would become PRC eligible through this
proposal. The MPTN states that the
Tribal members and American Indian
and Alaska Native (AI/AN) employees
who reside in the expanded counties are
socially and economically affiliated
with the Tribe, including through
employment and the utilization of direct
health care services. The MPTN would
like to recognize these persons as
eligible for PRC. Through
communication with MPTN’s
representatives, the IHS also
understands that MPTN’s members live
in all of the counties requested.
Accordingly, the IHS proposes to
expand the PRCDA of the Mashantucket
Pequot Tribal Nation to include the
Connecticut counties of Fairfield,
Hartford, Litchfield, Middlesex, New
Haven, Tolland, and Windham.
If the Mashantucket Pequot Tribal
Nation’s PRCDA expansion is finalized
as proposed, the Tribe’s PRCDA would
overlap completely with the PRCDA of
the Mohegan Tribe of Connecticut. The
Mohegan Tribe of Connecticut has
previously expressed support of any
future request made by a federally
recognized Tribe to establish the entire
VerDate Sep<11>2014
18:42 Jan 18, 2024
Jkt 262001
state of Connecticut as a PRCDA, and
has not expressed any objection to the
Mashantucket Pequot Tribal Nation’s
proposed PRCDA expansion.
Under 42 CFR 136.23, those otherwise
eligible Indians who do not reside on a
reservation, but reside within a PRCDA,
must be either members of the Tribe or
other IHS beneficiaries who maintain
close economic and social ties with the
Tribe. In this case, applying the
aforementioned PRCDA redesignation
criteria required by operative
regulations codified at 42 CFR part 136,
subpart C, the following findings are
made:
1. By expanding the PRCDA to
include Fairfield, Hartford, Litchfield,
Middlesex, New Haven, Tolland, and
Windham Counties, the Mashantucket
Pequot Tribal Nation’s eligible
population will be increase by an
estimated 32 Tribal members and AI/AN
employees.
2. The IHS finds that the Tribal
members and AI/AN employees within
the expanded PRCDA are socially and
economically affiliated with the
Mashantucket Pequot Tribal Nation
based on a tribal resolution in which the
MPTN Tribal Council identified its
intent to expand the PRCDA to include
all of Connecticut, and stated that the
Native Americans residing in such areas
are socially and economically affiliated
with MPTN.
3. The expanded PRCDA counties
form a contiguous area with the existing
PRCDA, and within one of the smallest
states. In addition to their AI/AN
employees, MPTN’s members reside in
each of the counties proposed for
inclusion. For these reasons, the IHS has
determined the additional counties
proposed for inclusion herein to be
geographically proximate, meaning ‘‘on
or near,’’ to the existing PRCDA.
4. The MPTN has indicated that its
PRC program can continue providing
the same level of care to the PRC eligible
population if the PRCDA is expanded as
proposed, without requiring additional
funding or reduction of the current
medical priority level.
This Notice does not contain
reporting or recordkeeping requirements
subject to prior approval by the Office
of Management and Budget under the
Paperwork Reduction Act of 1980.
Roselyn Tso,
Director, Indian Health Service.
[FR Doc. 2024–01017 Filed 1–18–24; 8:45 am]
BILLING CODE 4166–14–P
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Impact of
Toxicants on Aging and AD-related
Dementias.
Date: February 14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 7201
Wisconsin Avenue, Gateway Bldg., Suite
2W200, Bethesda, MD 20892, (301) 496–
9667, prasadnb@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: January 12, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–00952 Filed 1–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
E:\FR\FM\19JAN1.SGM
19JAN1
Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Genomics, Computational Biology and
Technology Study Section.
Date: February 13–14, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 2200,
Bethesda, MD 20892, 301–827–7088,
methode.bacanamwo@nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Arthritis, Connective Tissue and Skin Study
Section.
Date: February 13–14, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert Gersch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20817, (301) 867–5309, robert.gersch@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Accelerating Behavioral and Social Science
Through Ontology Development and Use.
Date: February 13, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting)
Contact Person: David E Pollio, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F,
Bethesda, MD 20892, (301) 594–4002,
polliode@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group
Kidney and Urological Systems Function and
Dysfunction Study Section.
Date: February 14–15, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2106,
Bethesda, MD 20892, (301) 435–5947,
banerjees5@mail.nih.gov.
VerDate Sep<11>2014
18:42 Jan 18, 2024
Jkt 262001
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group Pathophysiology of Eye Disease—2
Study Section.
Date: February 14–15, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cibu Paul Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review National Institutes of
Health 6701 Rockledge Drive, Room 1011–H
Bethesda, MD 20894 (301) 402–4341
thomascp@mail.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Social and Environmental Determinants of
Health Study Section.
Date: February 14–15, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ananya Paria, DHSC,
MPH, MS, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007H,
Bethesda, MD 20892, (301) 827–6513,
pariaa@mail.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neuroscience of
Basic Visual Processes Study Section.
Date: February 14–15, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242 kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
22–034: HEAL Initiative.
Date: February 14, 2024.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anne-Sophie Marie Lucie
Wattiez, Ph.D., Scientific Review Officer
Center, for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 594–4642, annesophie.wattiez@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
3671
Dated: January 16, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–01026 Filed 1–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Training and Workforce Development
Study Section—D Training & Workforce
Development Study Section D (TWD–D)—
Review of B2B, B2D & IRACDA Applications.
Date: February 23, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Sonia Ivette OrtizMiranda, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Bethesda, Maryland 20892, 301–402–
9448, sonia.ortiz-miranda@nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of PRAT and K99/R00
MOCSAC Applications.
Date: March 4–5, 2024.
Time: 10:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute of General Medical
Sciences, Natcher Building, 45 Center Drive,
Bethesda, Maryland 20892 (Virtual Meeting).
Contact Person: Tracy Koretsky, Ph.D.,
Scientific Review Officer, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Room 3AN12F, Bethesda, Maryland
20892, 301–594–2886, tracy.koretsky@
nih.gov.
E:\FR\FM\19JAN1.SGM
19JAN1
Agencies
[Federal Register Volume 89, Number 13 (Friday, January 19, 2024)]
[Notices]
[Pages 3670-3671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose
[[Page 3671]]
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Genomics, Computational Biology and Technology Study
Section.
Date: February 13-14, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Methode Bacanamwo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 2200, Bethesda, MD 20892, 301-827-
7088, [email protected].
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group; Arthritis, Connective Tissue and Skin Study
Section.
Date: February 13-14, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert Gersch, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Accelerating Behavioral and Social Science Through
Ontology Development and Use.
Date: February 13, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting)
Contact Person: David E Pollio, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1006F, Bethesda, MD 20892, (301)
594-4002, [email protected].
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group Kidney and Urological Systems Function and
Dysfunction Study Section.
Date: February 14-15, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Santanu Banerjee, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2106, Bethesda, MD 20892, (301)
435-5947, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group Pathophysiology of Eye Disease--2 Study
Section.
Date: February 14-15, 2024.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Cibu Paul Thomas, Ph.D., Scientific Review
Officer, Center for Scientific Review National Institutes of Health
6701 Rockledge Drive, Room 1011-H Bethesda, MD 20894 (301) 402-4341
[email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Social and Environmental Determinants of
Health Study Section.
Date: February 14-15, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ananya Paria, DHSC, MPH, MS, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007H, Bethesda, MD 20892, (301)
827-6513, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Neuroscience of Basic Visual
Processes Study Section.
Date: February 14-15, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications,
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242 [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-NS-22-034: HEAL Initiative.
Date: February 14, 2024.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anne-Sophie Marie Lucie Wattiez, Ph.D.,
Scientific Review Officer Center, for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892,
(301) 594-4642, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 16, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01026 Filed 1-18-24; 8:45 am]
BILLING CODE 4140-01-P